Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives

Health and Quality of Life Outcomes

Volumn 3, Issue , 2005, Pages

  Swigris, Jeffrey J ^a   Stewart, Anita L ^b   Gould, Michael K ^c,e   Wilson, Sandra R ^d,e  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d PALO ALTO MEDICAL FOUNDATION   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

Health related quality of life; Interstitial lung disease; Pulmonary fibrosis; Qualitative; Quality of life

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DEPENDENT PERSONALITY DISORDER; EMPLOYMENT; EXHAUSTION; EXPERIENCE; FAMILY; FINANCE; HUMAN; INFORMATION PROCESSING; INTERVIEW; LUNG FIBROSIS; MENTAL HEALTH; QUALITY OF LIFE; RELIGION; SEXUALITY; SLEEP; SYMPTOM; WELLBEING; ADULT; AGED; ATTITUDE TO HEALTH; COMORBIDITY; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; HEALTH STATUS INDICATOR; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; REPRODUCIBILITY; SICKNESS IMPACT PROFILE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CALIFORNIA; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOCUS GROUPS; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; PULMONARY FIBROSIS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 27644475951     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-3-61     Document Type: Article

References (20)

1. Joint Statement of the American Thoracic Society and the European Respiratory Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med 2000;161:646-664.
2. Coultas D, Zumwalt R, Black W, Sobonya R. The epidemiology of interstitial lung disease. Am J Respir Crit Care Med 1994;150:967-972.
3. Bjoraker JA, Ryu JH, Edwin MK, Meyers J, Tazelaar H, Schroeder D, Offord K. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199-203.
4. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell D, Harris J, Colby T, du Bois RM. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899-905.
5. Nicholson AG, Colby TV, du Bois RM, Hansell D, Wells A. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213-2217.
6. Flaherty KR, Toews GB, Lynch JP, 3rd, Kazerooni EA, Gross BH, Strawderman RL, Hariharan K, Flint A, Martinez FJ. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 2001;110:278-82.
7. Curtis J, Martin D, Martin T. Patient-assessed health outcomes in chronic lung disease: What are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997;156:1032-1039.
8. Chang J, Curtis R, Patrick D, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999;116:1175-1182.
9. Clark M, Cooper B, Singh S, Cooper M, Carr A, Hubbard R. A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis. Thorax 2001;56:482-486.
10. De Vries J, Kessels B, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001; 17:954-961.
11. De Vries J, Seebregts A, Drent M. Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir Med 2000;94:273-278.
12. Martinez J, Martinez T, Galhardo F, Pereira C. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis. Med Sci Mon 2002;8:CR405-CR410.
13. Martinez T, Pereira C, dos Santos M, Ciconelli R, Guimaraes S, Martinez J. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 2000;117:1627-1632.
14. The WHOQOL Group. The world health organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-1585.
15. Kaplan R, Bush J, Berry C. Health status: types of validity and the index of well-being. Health Serv Res 1976; 11:478-507.
16. Ware Jr. J, Sherbourne C. The MOS 36-item short-form health survey (SF-36). I. Coceptual framework and item selection. Med Care 1992;30:473-483.
17. Guyatt G, Berman L, Townsend M, Pugsley S, Chambers L. A measure of quality of life for clinical trials of chronic lung disease. Thorax 1987;42:773-778.
18. Jones P, Quirk F, Baveystock C. The St. George's Respiratory Questionnaire. Respir Med 1991;85:25-31.
19. Streiner D, Norman G. Health Measurement Scales: A practical guide to their development and use. New York: Oxford University Press, 1995.
20. Flanagan J. A research approach to improving our quality of life. Am Psychol 1978;33:138-147.